Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioSyent Schedules Fourth Quarter 2016 Earnings Release March" found in our extensive corporate database of over 50,000 company records.
Fourth Quarter 2011 Financial Highlights:
Fourth Quarter Highlights
Cimex Pharma AG is a Swiss-based specialty generics group, offering the generics industry a complete service range from product development and registration through to sourcing, manufacturing, packaging and logistics. Specialized in solid slow-release forms the Cimex Group supplies leading generics companies throughout Europe Cimex Generics will in the future directly supply the Swiss market with ...
March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit www.marchofdimes.com or www.nacersano.org.
The March of Dimes is a champion for all babies, and has protected for nearly 75 years. Beginning with funding the research that led to the eradication of polio in the U.S., the March of Dimes is the first and only organization that eradicated the disease it set out to eliminate, and also is the first health organization to host a nationwide walk.
The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies, the March of Dimes works to improve the health of babies. For the latest resources and information, visit marchofdimes.com or nacersano.org.
Nordson MARCH is the global leader in plasma processing technology for the semiconductor, printed circuit board (PCB), microelectronics, and medical & life science device manufacturing industries. Nordson MARCH has offices and applications laboratories worldwide, including California, Florida, Europe, Singapore, China, Japan, Korea and Taiwan. ...
InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180319005808/en/
Sensory Medical Inc. developed the pioneering Relaxis device, which is the first FDA approved, non-pharmacological approach to help improve the quality of sleep in patients with primary RLS. According to the National Institute of Neurological Disorders and Stroke, an estimated 12 million Americans currently suffer from RLS, a progressive neurological condi...
Based in Montreal (Canada), BioArtificial Gel Technologies operates in the biotechnology sector. Its mission is to develop and market systems for the progressive release of active agents based on a hydrogel technological springboard. Through intensive research, the firm has succeeded in perfecting a new generation of hydrogels for a wide range of applications. A true release vector in the form of ...
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of small molecule and antibody agents that target the immune system to treat patients with cancer. These agents block or modify crucial immune checkpoints and reprogram immune T cells. A Phase 1B clinical trial evaluating its oral small molecule checkpoint inhib...
Based in London, Synthace is developing Antha, a language and software platform specifically for biology that lets researchers aim higher and achieve better results, faster. Antha is designed to make reproducible and scalable workflows that can be readily edited and shared, and easily automated on labsâ existing equipment. In 2016, the World Economic Forum ...
Verisma is a health information technology provider focused on delivering unparalleled Disclosure Management solutions. The companyâs flagship automation system, VerismaÂ® Release Manager (VRM), is utilized by well-known healthcare organizations nationwide. VRM automates workflow to improve turnaround times, reduce errors and drive down costs â...
For more than a quarter of a century, Innovative Research of America has assumed the leadership role in improved time release technology. The main mission is to standardize the technology of drug delivery. Our proven Time Release Hormone and Drug Pellets help investigators take charge of product delivery and expand their abilities to do meaningful and reproducible research.Since it is not easy to ...
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150710005701/en/
Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies. The Company’s drug development efforts are based on three commercialized technology platforms; bioavailability enhancement of poorly soluble drugs, customized release and taste masked/fast dissolving formulations. Eurand has recently a...
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151215005504/en/
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170606005891/en/
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180427006057/en/
Gyros Protein Technologies is a leading provider of sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. Formed in March 2016 by the merger of Gyros AB and Protein Technologies, Inc., the Company combines Gyrosâ microfluidics, systems development and immunoassay expertise with Protein Tech...
Welcome to Improved Outcomes SoftwareImproved Outcomes Software (IOS) is pleased to announce the release of GeneLinker(TM) Gold and Platinum 4.6, new versions of the award-winning Gene Expression and Proteomics Analysis Software products. See the full press release for more details. This is also the first release of GeneLinker by Improved Outcomes Software Inc. (following Predictive Patterns Softw...
MINRAD INTERNATIONAL, INC. is an innovator in acute care medical devices and pharmaceuticals. The company’s medical device products incorporate patented real time image-guidance technologies that enable medical professionals to improve the accuracy of interventional procedures and provide a significant reduction in radiation exposure for both patients and medical professionals. MINRAD’s presen...
ACTIPAC is offering a novel technology of advanced nano- and micro-encapsulation of sensitive, highly active drugs. Its main focus is the development of controlled release formulations (sustained release).